These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25142389)

  • 1. [Evaluation of potentially influential factors for positron emission tomography image quality in liver signal-to-noise ratio utilizing a delivery ¹⁸F-fluoro-2-deoxy-D-glucose study on Bi₄Ge₃O₁₂-positron emission tomography/computed tomography].
    Kangai Y; Onishi H; Takigawa A; Yoshikawa K; Sanai H; Mimura H; Yanagimoto S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Aug; 70(8):784-92. PubMed ID: 25142389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.
    Masuda Y; Kondo C; Matsuo Y; Uetani M; Kusakabe K
    J Nucl Med; 2009 Jun; 50(6):844-8. PubMed ID: 19443586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimization of the scan time is based on the physical index in FDG-PET/CT].
    Shimada N; Daisaki H; Murano T; Terauchi T; Shinohara H; Moriyama N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2011; 67(10):1259-66. PubMed ID: 22026978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
    Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
    Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of optimized injection dose and acquisition time using body mass index for three-dimensional whole-body FDG-PET].
    Matsumoto K; Matsuura H; Minota E; Sakamoto S; Nakamoto Y; Senda M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2004 Nov; 60(11):1564-73. PubMed ID: 15568009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of Determining Acquisition Time by True Count Rate Measurement Method for Delivery 18F-FDG PET/CT].
    Miura S; Odashima S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Mar; 72(3):218-26. PubMed ID: 27000670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified signal-to-noise ratio in the liver using the background-to-lung activity ratio to assess image quality of whole-body
    Yamashita S; Okuda K; Nakaichi T; Yamamoto H; Yoneyama T; Yokoyama K
    Radiol Phys Technol; 2023 Mar; 16(1):94-101. PubMed ID: 36683121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by
    Xiao J; Yu H; Sui X; Hu Y; Cao Y; Liu G; Zhang Y; Hu P; Wang Y; Li C; Xu B; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):269-278. PubMed ID: 34185138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise.
    Yan J; Schaefferkoette J; Conti M; Townsend D
    Cancer Imaging; 2016 Aug; 16(1):26. PubMed ID: 27565136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
    Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEC density and liver ROI S/N ratio for image quality control of whole-body FDG-PET scans: comparison with visual assessment.
    Mizuta T; Senda M; Okamura T; Kitamura K; Inaoka Y; Takahashi M; Matsumoto K; Abe M; Shimonishi Y; Shiomi S
    Mol Imaging Biol; 2009; 11(6):480-6. PubMed ID: 19330382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
    Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography image quality between commercial and in-house supply of FDG radiopharmaceuticals].
    Wagatsuma K; Miwa K; Miyaji N; Murata T; Umeda T; Osawa A; Takiguchi T; Koizumi M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Apr; 70(4):339-45. PubMed ID: 24759214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.